← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$961K

Shares

220,000

Price

$4

Filed

Dec 4

Insider

Name

Borgeson Blake

Title

CIK

0001856094

Roles

Director

Transaction Details

Transaction Date

2025-12-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,869,863

Footnotes

This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.

Filing Info

Accession No.

0001856094-25-000006

Form Type

4

Issuer CIK

0001601830

Borgeson Blake's History

Date Ticker Type Value
2026-04-07 RXRX $93K
2026-01-06 RXRX $959K
2025-12-02 RXRX $961K
2025-06-18 RXRX A $0
2025-06-18 RXRX A $0

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $93K 2026-04-07
Gibson Christopher $254K 2026-04-07